| 000 | 00905 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513203100.0 | ||
| 264 | 0 | _c20000228 | |
| 008 | 200002s 0 0 swe d | ||
| 022 | _a0023-7205 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStarmark, J E | |
| 245 | 0 | 0 |
_a[When disease insight is halting. II. The neurobiological underpinnings]. _h[electronic resource] |
| 260 |
_bLakartidningen _cJan 2000 |
||
| 300 |
_a328-31 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdaptation, Psychological |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAwareness |
| 650 | 0 | 4 | _aCognition |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 700 | 1 | _aHellström, P H | |
| 700 | 1 | _aAgren, H | |
| 773 | 0 |
_tLakartidningen _gvol. 97 _gno. 4 _gp. 328-31 |
|
| 999 |
_c10638507 _d10638507 |
||